Reuters: Health
Novartis has received approval from the U.S. Food and Drug Administration for its Beovu drug to treat a cause of vision loss, the Swiss pharmaceuticals company said on Tuesday.
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment